Screening indicators to evaluate the clinical significance of drug-drug interactions in polypharmacy among older adults with psychiatric disorders: a delphi study

Yu Liu,Xuefeng Li,Man Yang,Yaping Ding,Minghui Ji
DOI: https://doi.org/10.1186/s12888-024-05872-3
IF: 4.144
2024-06-05
BMC Psychiatry
Abstract:Polypharmacy is common in older adults with psychiatric disorders, but no consensus has reached about the reliable indicators evaluating the benefits and risks of drug-drug interactions (DDIs) in polypharmacy. We aimed to identify indicators suitable for evaluating the clinical significance of DDIs in polypharmacy in older adults with psychiatric disorders.
psychiatry
What problem does this paper attempt to address?